Search
Profil Pasien Kanker Paru Primer yang Dirawat Inap dan Rawat Jalan di Rumah Sakit Umum Daerah Dr Soetomo Surabaya [Profile of Primary Lung Cancer Patients in Dr. Soetomo General Hospital Surabaya]
65-71
Abstract : 2022
PDF : 3836
Neutrophil-Lymphocyte Ratio (NLR) as a Prognostic Marker in Advanced Lung Cancer Patients Undergoing First-Line Treatment
209-213
Abstract : 384
PDF : 111
The Effect of Anemia on Prognostic in Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
120-129
Abstract : 399
PDF : 205
The Influence of Nigella sativa on the Increase of IFN-γ and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy
31-38
Abstract : 368
PDF : 62
Volatile Organic Compounds (VOC) and Serum Leukotriene B4 between COPD Patients and COPD with Lung Cancer Patients
222-227
Abstract : 292
PDF : 147
Giant Cell Lung Carcinoma: A Case Report of a Rare Histology Type of Non-Small Cell Lung Cancer
143-148
Abstract : 458
PDF : 211
Assessment of Quality of Life in Advanced-Stage Lung Cancer Patients Using EORTC QLQ-C30 Questionnaire
228-235
Abstract : 358
PDF : 166
Risk Factors and Challenging Management of Lung Adenocarcinoma in Young Adult Women: Case Series
94-98
Abstract : 1013
PDF : 408
Efek Samping Hematologi Akibat Kemoterapi dan Tatalaksananya [Hemathologic Adverse Effect Related to Chemotherapy]
22-28
Abstract : 3922
PDF : 48846
Hematologic Paraneoplastic Syndrome in Newly Diagnosed Patients with Lung Cancer
18-29
Abstract : 755
PDF : 608
The Effects of Inspiratory Muscle Training in Lung Cancer Patients: A Scoping Review
75-82
Abstract : 130
PDF : 73
Anaplastic Lymphoma Kinase (ALK) Rearrangement of Lung Adenocarcinoma among North Sumatera Population
47-53
Abstract : 111
PDF : 57
The Time to Progression in Lung Adenocarcinoma Patients Receiving First- and Second-Generation EGFR-TKI in Indonesia
22-30
Abstract : 262
PDF : 97
Implementing Palliative and End-of-Life Care in Lung Cancer: When to Start?
64-71
Abstract : 657
PDF : 497
Nutrisi pada Penderita Kanker Paru [Nutrition Management in Lung Cancer Patients]
91-100
Abstract : 2220
PDF : 15170
Volatile Organic Compounds (VOCs) and Interleukin-23 Levels in Lung Cancer: A Future Biomarker
80-86
Abstract : 708
PDF : 421
Problem Penegakkan Diagnostik Pasien dengan Massa di Paru [Diagnostic Problems in Lung Mass Management]
41-46
Abstract : 1573
PDF : 21775